AILERON THERAPEUTICS INC (ALRN) Stock Analyst Ratings
USA - NASDAQ:ALRN - US00887A2042 - Common Stock
2.11 USD
+0.18 (+9.33%)
2.11 USD
0 (0%)
ChartMill assigns a Buy % Consensus number of 85% to ALRN. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 13.26. This target is 528.44% above the current price.
ALRN was analyzed by 8 analysts. The buy percentage consensus is at 85. So analysts seem to be very confident about ALRN.
In the previous month the buy percentage consensus was at a similar level.
ALRN was analyzed by 8 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-04-18 | Ladenburg Thalmann | Maintains | Buy -> Buy |
| 2023-12-01 | Ladenburg Thalmann | Upgrade | Neutral -> Buy |
| 2022-06-30 | HC Wainwright & Co. | Maintains | Buy |
| 2022-06-29 | William Blair | Downgrade | Outperform -> Market Perform |
AILERON THERAPEUTICS INC / ALRN FAQ
What do analysts expect the price target to be for AILERON THERAPEUTICS INC (ALRN)?
8 analysts have analysed ALRN and the average price target is 13.26 USD. This implies a price increase of 528.44% is expected in the next year compared to the current price of 2.11.
Can you provide the consensus rating for AILERON THERAPEUTICS INC stock?
The consensus rating for AILERON THERAPEUTICS INC (ALRN) is 85 / 100 . This indicates that analysts generally have a positive outlook on the stock.